These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11599484)

  • 1. [Hepatic fibrosis].
    Kershenobich D; Gutiérrez-Ruiz MC
    Rev Invest Clin; 2001; 53(4):357-61. PubMed ID: 11599484
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic venous pressure gradient supplements liver biopsy in the diagnosis of cirrhosis.
    Wolf AT; Maurer R; Glickman J; Grace ND
    J Clin Gastroenterol; 2008 Feb; 42(2):199-203. PubMed ID: 18209592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis.
    Gómez-Dominguez E; Mendoza J; García-Buey L; Trapero M; Gisbert JP; Jones EA; Moreno-Otero R
    Aliment Pharmacol Ther; 2008 Mar; 27(5):441-7. PubMed ID: 18081731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [When hepatic fibrosis becomes a disease...].
    Grimaud JA; Druguet M; Hartmann D
    Gastroenterol Clin Biol; 1988 Feb; 12(2):87-8. PubMed ID: 3366324
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrosis and cirrhosis reversibility: clinical features and implications.
    Pinzani M; Vizzutti F
    Clin Liver Dis; 2008 Nov; 12(4):901-13, x. PubMed ID: 18984473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver fibrosis and cirrhosis: are they reversible?].
    Kershenobich D
    Rev Gastroenterol Mex; 2004 Nov; 69 Suppl 3():149-51. PubMed ID: 16881220
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrosis in chronic liver diseases: diagnosis and management.
    Pinzani M; Rombouts K; Colagrande S
    J Hepatol; 2005; 42 Suppl(1):S22-36. PubMed ID: 15777570
    [No Abstract]   [Full Text] [Related]  

  • 8. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
    Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutical targets for revert liver fibrosis].
    García B L; Gálvez G J; Armendáriz B J
    Rev Med Chil; 2007 Jun; 135(6):783-91. PubMed ID: 17728907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cirrhosis--can we reverse hepatic fibrosis?
    Tangkijvanich P; Yee HF
    Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic fibrosis influences the growth of hepatocellular carcinoma.
    Osada S; Kanematsu M; Imai H; Goshima S; Sugiyama Y
    Hepatogastroenterology; 2008; 55(81):184-7. PubMed ID: 18507103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
    Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
    Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.
    Kaneda H; Hashimoto E; Yatsuji S; Tokushige K; Shiratori K
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1459-65. PubMed ID: 16911693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preface. Hepatic fibrosis: pathogenesis, diagnosis, and emerging therapies.
    Friedman SL
    Clin Liver Dis; 2008 Nov; 12(4):xiii-xiv. PubMed ID: 18984462
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.
    Xie SB; Yao JL; Zheng RQ; Peng XM; Gao ZL
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
    Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver fibrosis: non-invasive assessment with MR elastography.
    Huwart L; Peeters F; Sinkus R; Annet L; Salameh N; ter Beek LC; Horsmans Y; Van Beers BE
    NMR Biomed; 2006 Apr; 19(2):173-9. PubMed ID: 16521091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.
    Denzer UW; Lüth S
    Best Pract Res Clin Gastroenterol; 2009; 23(3):453-60. PubMed ID: 19505671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive measures of liver fibrosis.
    Rockey DC; Bissell DM
    Hepatology; 2006 Feb; 43(2 Suppl 1):S113-20. PubMed ID: 16447288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic fibrosis--role of hepatic stellate cell activation.
    Safadi R; Friedman SL
    MedGenMed; 2002 Jul; 4(3):27. PubMed ID: 12466770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.